阿托伐他汀在缺血性卒中患者中的疗效研究  

Study on curative effects of atorvastatin on patients with ischemic stroke

作　　者：栾松[1] 黄晓勇[1] 刘娟[1] 潘华[1] 栾雯[1] 李浩东[1] 范永新[1] 

机构地区：[1]解放军301医院合作医院涿州市医院,河北涿州072750

出　　处：《西南国防医药》2015年第1期7-9,共3页Medical Journal of National Defending Forces in Southwest China

基　　金：河北省科技支撑计划项目(20130687)

摘　　要：目的探讨阿托伐他汀对缺血性卒中患者的疗效。方法收集2012年6月-2014年2月来我院诊治的缺血性卒中患者311例为研究对象,依据其来诊的顺序随机分为实验组与对照组。两组均给予常规内科治疗,实验组加用阿托伐他汀治疗,治疗3个月后,观察两组的治疗效果。结果实验组的临床疗效明显高于对照组;治疗后实验组的总胆固醇、甘油三酯及低密度脂蛋白明显低于对照组,而高密度脂蛋白明显高于对照组。结论阿托伐他汀可以改善缺血性卒中患者血脂水平,提高缺血性卒中患者的治疗效果。Objective To explore the curative effects of atorvastatin on patients with ischemic stroke. Methods Total 311 patients who were suffering from ischemic stroke and receiving treatment in our hospital from Jun. 2012 to Feb. 2014 were selected and divided randomly into the experiment group and control group. Both groups were provided with conventional treatment and the experiment group was additionally administered with atorvastatin. After treatment for three months,the curative effects in both groups were observed and compared. Results The clinical curative effect of the experimental group was significantly higher than that of the control group; after the treatment,the total cholesterol,triglyceride and low-density lipoprotein of the experimental group were significantly lower than those of the control group,and the high-density lipoprotein was significantly higher than that of the control group. Conclusion Atorvastatin can improve blood lipid levels of patients with ischemic stroke,and improve the curative effect on patients with ischemic stroke.

关 键 词：阿托伐他汀 缺血 卒中 疗效 

分 类 号：R743[医药卫生—神经病学与精神病学]